Yuting Ji

900 total citations · 1 hit paper
44 papers, 542 citations indexed

About

Yuting Ji is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Yuting Ji has authored 44 papers receiving a total of 542 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 11 papers in Oncology and 7 papers in Surgery. Recurrent topics in Yuting Ji's work include Cell death mechanisms and regulation (5 papers), Global Cancer Incidence and Screening (4 papers) and interferon and immune responses (3 papers). Yuting Ji is often cited by papers focused on Cell death mechanisms and regulation (5 papers), Global Cancer Incidence and Screening (4 papers) and interferon and immune responses (3 papers). Yuting Ji collaborates with scholars based in China, Canada and United Kingdom. Yuting Ji's co-authors include Junjie Luo, Peng An, Shuaishuai Zhou, Zhe Wang, Jiaping Wang, Xiqi Jian, Lanlan Wei, Xuan Wang, Yongting Luo and Sudan He and has published in prestigious journals such as ACS Nano, PLoS ONE and Scientific Reports.

In The Last Decade

Yuting Ji

40 papers receiving 535 citations

Hit Papers

Global burden of cervical cancer: current estimates, temp... 2025 2026 2025 5 10 15

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuting Ji China 14 228 111 84 72 69 44 542
Yiting Sun China 14 235 1.0× 172 1.5× 110 1.3× 62 0.9× 118 1.7× 41 680
Ke Zhu China 17 214 0.9× 116 1.0× 62 0.7× 81 1.1× 69 1.0× 33 594
Dazhi Cen United States 4 223 1.0× 112 1.0× 91 1.1× 46 0.6× 45 0.7× 7 474
Yanfang Wang China 17 174 0.8× 176 1.6× 50 0.6× 91 1.3× 54 0.8× 31 577
İlhan Yaylım Türkiye 17 395 1.7× 144 1.3× 160 1.9× 53 0.7× 60 0.9× 76 798
Jingyi Zhang China 16 267 1.2× 154 1.4× 122 1.5× 71 1.0× 200 2.9× 70 780
Xin Cai China 13 178 0.8× 62 0.6× 44 0.5× 41 0.6× 41 0.6× 39 545
Camila Maria Longo Machado Brazil 14 257 1.1× 145 1.3× 106 1.3× 129 1.8× 102 1.5× 28 742
Yang Zou China 18 384 1.7× 101 0.9× 99 1.2× 69 1.0× 45 0.7× 71 832
Ailing Wei China 9 201 0.9× 108 1.0× 67 0.8× 60 0.8× 38 0.6× 22 658

Countries citing papers authored by Yuting Ji

Since Specialization
Citations

This map shows the geographic impact of Yuting Ji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuting Ji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuting Ji more than expected).

Fields of papers citing papers by Yuting Ji

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuting Ji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuting Ji. The network helps show where Yuting Ji may publish in the future.

Co-authorship network of co-authors of Yuting Ji

This figure shows the co-authorship network connecting the top 25 collaborators of Yuting Ji. A scholar is included among the top collaborators of Yuting Ji based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuting Ji. Yuting Ji is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Siwen, Yunmeng Zhang, Yuting Ji, et al.. (2025). Severe obesity, high inflammation, insulin resistance with risks of all-cause mortality and all-site cancers, and potential modification by healthy lifestyles. Scientific Reports. 15(1). 1472–1472. 6 indexed citations
2.
Ji, Yuting, Jingjing Li, Haikuo Ma, et al.. (2025). Discovery of Zharp1-163 as a dual inhibitor of ferroptosis and necroptosis for the treatment of inflammatory disorders and kidney injury. Cell Death Discovery. 11(1). 413–413.
3.
4.
Liu, Xiaomin, Siwen Liu, Yunmeng Zhang, et al.. (2024). Preliminary effects of risk-adapted PSA screening for prostate cancer after integrating PRS-specific and age-specific variation. Frontiers in Genetics. 15.
5.
Liu, Xiaomin, Yu Zhang, Ya Liu, et al.. (2024). Risk-stratified CA125 screening integrating CA125 trajectories, trajectory-specific progression and transvaginal ultrasound for ovarian cancer. Journal of Ovarian Research. 17(1). 1 indexed citations
6.
Wang, Meiyu, et al.. (2024). Effect of mode of delivery on postpartum weight retention: A systematic review and meta-analysis. Midwifery. 132. 103981–103981.
7.
Zhou, Feifan, et al.. (2024). Highly efficient semiconductor modules making controllable parallel microchannels for non-compressible hemorrhages. Bioactive Materials. 36. 30–47. 11 indexed citations
8.
Ji, Yuting, Sheng Xu, Cuige Zhang, et al.. (2023). A molecularly imprinted sensor based on thermo-responsive calcium alginate nanohydrogels for lysozyme detection. Colloid & Polymer Science. 301(3). 229–237. 7 indexed citations
9.
Li, Yao, Jie Wang, Yaru Li, et al.. (2023). Attenuating Uncontrolled Inflammation by Radical Trapping Chiral Polymer Micelles. ACS Nano. 17(13). 12127–12139. 12 indexed citations
11.
Wang, Xuan, Yuting Ji, Shuaishuai Zhou, et al.. (2023). Mitochondrial carrier 1 (MTCH1) governs ferroptosis by triggering the FoxO1-GPX4 axis-mediated retrograde signaling in cervical cancer cells. Cell Death and Disease. 14(8). 508–508. 40 indexed citations
12.
Wang, Zhe, Shuaishuai Zhou, Yuting Ji, et al.. (2023). Regulatory roles of copper metabolism and cuproptosis in human cancers. Frontiers in Oncology. 13. 1123420–1123420. 77 indexed citations
13.
An, Peng, et al.. (2023). Food groups and urologic cancers risk: a systematic review and meta-analysis of prospective studies. Frontiers in Nutrition. 10. 1154996–1154996. 3 indexed citations
14.
Ji, Yuting, et al.. (2021). Expression of COX-2 and Nrf2/GPx3 in the anterior vaginal wall tissues of women with pelvic organ prolapse. Archives of Gynecology and Obstetrics. 303(5). 1245–1253. 8 indexed citations
15.
Zhu, Fang, Chengkui Yang, S. C. Wu, et al.. (2020). Discovery of a Potent RIPK3 Inhibitor for the Amelioration of Necroptosis-Associated Inflammatory Injury. Frontiers in Cell and Developmental Biology. 8. 606119–606119. 38 indexed citations
16.
Wang, Yao, Hailiang Liu, Yingmei Fu, et al.. (2019). Novel biomarkers containing citrullinated peptides for diagnosis of systemic lupus erythematosus using protein microarrays.. PubMed. 37(6). 929–936. 6 indexed citations
17.
Ji, Yuting, et al.. (2019). Changes in β-Catenin Expression in the Anterior Vaginal Wall Tissues of Women With Pelvic Organ Prolapse: A Potential Pathophysiological Mechanism. Female Pelvic Medicine & Reconstructive Surgery. 26(11). e54–e61. 3 indexed citations
18.
Zhao, Yu, et al.. (2017). Prognostic analysis for Chinese patients with stage I ovarian endometrioid carcinoma. Journal of Ovarian Research. 10(1). 63–63. 9 indexed citations
19.
Li, Jinyuan, Yuting Ji, Ming Ren, et al.. (2015). Inconclusive role of human papillomavirus infection in breast cancer. Infectious Agents and Cancer. 10(1). 36–36. 20 indexed citations
20.
He, Junming, Yuting Ji, Aimei Li, et al.. (2014). MiR-122 Directly Inhibits Human Papillomavirus E6 Gene and Enhances Interferon Signaling through Blocking Suppressor of Cytokine Signaling 1 in SiHa Cells. PLoS ONE. 9(9). e108410–e108410. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026